# Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study

Study · id `cardio:ct-nct01243827` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01243827](<https://clinicaltrials.gov/study/NCT01243827>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01243827

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01243827. Randomized; no masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01243827, source copy `cardio:ctgov-nct01243827-2012-07-19`, retrieved 2026-10-26)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01243827, source copy `cardio:ctgov-nct01243827-2012-07-19`, retrieved 2026-10-26)
- Primary completion: 2012-12 (anticipated) (ClinicalTrials.gov record NCT01243827, source copy `cardio:ctgov-nct01243827-2012-07-19`, retrieved 2026-10-26)
- Completion: 2013-04 (anticipated) (ClinicalTrials.gov record NCT01243827, source copy `cardio:ctgov-nct01243827-2012-07-19`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01243827, source copy `cardio:ctgov-nct01243827-2012-07-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01243827-2012-07-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study
- Condition: Hypertension
- Intervention (Drug): carvedilol
- Intervention (Drug): bisoprolol
- Lead sponsor: Yoshio Matsui
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Carvedilol (`cardio:carvedilol`)
- Registry intervention name matches this record: Bisoprolol (`cardio:bisoprolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)

## Provenance

Content hash: efa0df7222b74dcbb5dd8a02659c43b5e9838145054226333f0b121938bb3e94
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
